Stereotactic body radiation therapy can promote tumor cells to release stromal cell-derived factor-1 α (SDF-1α) and platelet-derived growth factor-B (PDGFR-B) to bind to the corresponding ligands, resulting in bone marrow mesenchymal stem cells to migrate into the tumor parenchyma. Here, PDGFRB is linked to neoplasm.